Edition:
United Kingdom

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.60USD
7:34pm GMT
Change (% chg)

$-0.03 (-4.07%)
Prev Close
$0.63
Open
$0.62
Day's High
$0.62
Day's Low
$0.60
Volume
42,835
Avg. Vol
108,366
52-wk High
$2.55
52-wk Low
$0.48

Chart for

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 1.81
Market Cap(Mil.): $299.88
Shares Outstanding(Mil.): 147.00
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.25 -- --
ROI: -109.40 8.99 14.48
ROE: -411.96 10.13 15.99

Earnings vs. Estimates